Koichi Minato

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

Yukio Hosomi, Satoshi Morita, Shunichi Sugawara et al. · Journal of Clinical Oncology · 2019 · 473 citations

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03

Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida et al. · European Journal of Cancer · 2009 · 339 citations

Advanced Lung Disease, Medicine, Immunology +7

Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: Characterization and mechanism of resistance

Fumihiko Kanzawa, Yoshikazu Sugimoto, Koichi Minato et al. · Lung Cancer · 1991 · 167 citations

Oncology, Camptothecin Analogue, Medicine +11

Phase III study comparing gefitinib monotherapy (G) to combination therapy with gefitinib, carboplatin, and pemetrexed (GCP) for untreated patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009).

Atsushi Nakamura, Akira Inoue, Satoshi Morita et al. · Journal of Clinical Oncology · 2018 · 112 citations

Cancer Management, Gefitinib Monotherapy, Pathology +19

Randomized Phase III Trial Comparing Weekly Docetaxel Plus Cisplatin Versus Docetaxel Monotherapy Every 3 Weeks in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Intergroup Trial JCOG0803/WJOG4307L

Tetsuya Abe, Koji Takeda, Yuichiro Ohe et al. · Journal of Clinical Oncology · 2015 · 110 citations · Full text